课题基金 / 基金详情

Molecular characterization of IPMN using comprehensive genome analysis

Molecular characterization of IPMN using comprehensive genome analysis
使用综合基因组分析对 IPMN 进行分子表征
批准号:
23591010
负责人:
TADA Minoru
金额:
$3.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
关键词:

项目摘要

项目成果

TADA Minoru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We characterized the molecular signature of IPMN in this project. 11 gastric, 11 intestinal, one pancreatobiliary, and two oncocytic types were included in this study. We compared the molecular characteristics of two major subtypes, gastric-type and intestinal-type IPMN. Gastric-type showed a higher incidence of KRAS mutations (9/11, 81.8%) compared with intestinal type (3/11, 27.3%). The intestinal type (9/11, 81.8%) demonstrated more frequent SMAD1/5/8 phosphorylation compared with gastric-type IPMN (3/11, 27.3%).In addition, we identified a molecule that accerelated epithelial- mesenchymal transition in pancreas cancer cells. The gene was amplified in pancreas cancer cells and human pancreatic tumors. We now examine the significance of the molecule in IPMN as well as in pancreatic cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.5009/gnl.2013.7.6.725
发表时间: 2013-11
期刊: Gut and liver
影响因子: 3.4
作者: [Isayama H, Kawakubo K, Nakai Y, Inoue K, Gon C, Matsubara S, Kogure H, Ito Y, Tsujino T, Mizuno S, Hamada T, Uchino R, Miyabayashi K, Yamamoto K, Sasaki T, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K]
通讯作者: Koike K
DOI: 10.1007/s00280-010-1360-7
发表时间: 2011-04-01
期刊: CANCER CHEMOTHERAPY AND PHARMACOLOGY
影响因子: 3
作者: [Sasaki, Takashi, Isayama, Hiroyuki, Koike, Kazuhiko]
通讯作者: Koike, Kazuhiko
DOI: 10.1038/bjc.2012.183
发表时间: 2012-06-05
期刊: British journal of cancer
影响因子: 8.8
作者: [Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Toda N, Kogure H, Matsubara S, Ito Y, Togawa O, Arizumi T, Hirano K, Tada M, Omata M, Koike K]
通讯作者: Koike K
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial
使用利培酮预防 ERCP 后胰腺炎的东京试验 (Tokyo P3R) 的结果:一项多中心、随机、II 期、非安慰剂对照试验
DOI: --
发表时间: 2013
期刊: J Gastroenterol
影响因子: 6.3
作者: [Tsujino T, Isayama H, Nakai Y, Ito Y, Togawa O, Toda N, Arizumi T, Kogure H, Yamamoto K, Mizuno S, Yashima Y, Yagioka H, Sasaki T, Matsubara S, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K]
通讯作者: Koike K
71
    Mechanisms of the immune responses related to adverse reactions of therapeutic mAbs
    • 批准号:
      15K18884
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2015
    • 负责人:
      TADA Minoru
    • 依托单位:
    Effects of immune-complex formation on the biological activities of anti-TNFalpha monoclonal antibody products
    • 批准号:
      24790183
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      TADA Minoru
    • 依托单位:
    Estimation of pancreatic cancer development by assessment and genetic analysis of precursor lesion of pancreatic cancer
    • 批准号:
      18590720
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.62万
    • 财政年份:
      2006
    • 负责人:
      TADA Minoru
    • 依托单位:
    Analysis of relationship between chemo-sensitivity and gene expression profile in pancreatic cancer by using specimen obtained by endoscopic ultrasonography guided fine needle aspiration biopsy for clinical application
    • 批准号:
      14570447
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2002
    • 负责人:
      TADA Minoru
    • 依托单位:
    海外基金